GE HealthCare Technologies Inc (NASDAQ: GEHC) closed the day trading at $88.48 down -3.64% from the previous closing price of $91.82. In other words, the price has decreased by -$3.34 from its previous closing price. On the day, 14427667 shares were traded.
Ratios:
For a better understanding of GEHC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.51. For the most recent quarter (mrq), Quick Ratio is recorded 0.78 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 1.38 whereas as Long-Term Debt/Eq ratio is at 1.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, HSBC Securities on February 15, 2024, initiated with a Buy rating and assigned the stock a target price of $100.
On February 12, 2024, UBS Upgraded its rating to Neutral which previously was Sell and also upped its target price recommendation from $66 to $88.
On November 30, 2023, Jefferies started tracking the stock assigning a Hold rating and target price of $80.Jefferies initiated its Hold rating on November 30, 2023, with a $80 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 31 ’23 when O’Neill Kevin Michael sold 15,609 shares for $77.32 per share. The transaction valued at 1,206,949 led to the insider holds 24,025 shares of the business.
Rott Roland sold 2,473 shares of GEHC for $191,336 on Jun 08 ’23. The CEO, Ultrasound now owns 22,335 shares after completing the transaction at $77.37 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GEHC now has a Market Capitalization of 40.29B and an Enterprise Value of 47.66B. As of this moment, GE’s Price-to-Earnings (P/E) ratio for their current fiscal year is 29.25, and their Forward P/E ratio for the next fiscal year is 18.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.06 while its Price-to-Book (P/B) ratio in mrq is 5.65. Its current Enterprise Value per Revenue stands at 2.44 whereas that against EBITDA is 13.57.
Stock Price History:
Over the past 52 weeks, GEHC has reached a high of $94.50, while it has fallen to a 52-week low of $62.35. The 50-Day Moving Average of the stock is 81.72, while the 200-Day Moving Average is calculated to be 74.90.
Shares Statistics:
Over the past 3-months, GEHC traded about 3.24M shares per day on average, while over the past 10 days, GEHC traded about 4.22M shares per day. A total of 455.34M shares are outstanding, with a floating share count of 407.28M. Insiders hold about 10.56% of the company’s shares, while institutions hold 70.14% stake in the company. Shares short for GEHC as of Feb 29, 2024 were 13.21M with a Short Ratio of 4.07, compared to 15.66M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.90% and a Short% of Float of 3.62%.
Dividends & Splits
GEHC’s forward annual dividend rate is 0.12, up from 0.12 a year ago. Against a Trailing Annual Dividend Yield of 0.13%, it implies a Forward Annual Dividend Yield of 0.14%.
Earnings Estimates
Current recommendations for the stock of the company come from 11 analysts. On average, analysts expect EPS of $0.9 for the current quarter, with a high estimate of $0.96 and a low estimate of $0.87, while EPS last year was $0.85. The consensus estimate for the next quarter is $1.01, with high estimates of $1.05 and low estimates of $0.97.
Analysts are recommending an EPS of between $4.33 and $4.21 for the fiscal current year, implying an average EPS of $4.29. EPS for the following year is $4.83, with 13 analysts recommending between $4.91 and $4.76.
Revenue Estimates
10 analysts predict $4.8B in revenue for the current quarter. It ranges from a high estimate of $4.92B to a low estimate of $4.67B. As of the current estimate, GE HealthCare Technologies Inc’s year-ago sales were $4.71B, an estimated increase of 2.00% from the year-ago figure. For the next quarter, 10 analysts are estimating revenue of $4.97B, an increase of 3.20% over than the figure of $2.00% in the same quarter last year. There is a high estimate of $5.05B for the next quarter, whereas the lowest estimate is $4.92B.
A total of 14 analysts have provided revenue estimates for GEHC’s current fiscal year. The highest revenue estimate was $20.53B, while the lowest revenue estimate was $20.16B, resulting in an average revenue estimate of $20.31B. In the same quarter a year ago, actual revenue was $19.55B, up 3.90% from the average estimate. Based on 14 analysts’ estimates, the company’s revenue will be $21.32B in the next fiscal year. The high estimate is $21.8B and the low estimate is $21.14B. The average revenue growth estimate for next year is up 5.00% from the average revenue estimate for this year.
